Growth Metrics

Ceribell (CBLL) Gains from Sales and Divestitures (2024 - 2026)

Ceribell posted quarterly Gains from Sales and Divestitures of $96073.0 for Q1 2026, up 670.56% year-on-year from $12468.0 in Q1 2025, and down 51.96% on a QoQ basis from $199975.0 in Q4 2025.

Ceribell (CBLL) has 3 years of Gains from Sales and Divestitures data on file, last reported at $96073.0 in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 670.56% year-over-year to $96073.0; the trailing twelve-month figure through Mar 2026 stood at $96073.0 (up 670.56% YoY), and the FY2025 full-year result was $199975.0, up 16040.03% from the prior year.
  • Gains from Sales and Divestitures for Q1 2026 stood at $96073.0, down from $199975.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $199975.0 in Q4 2025 and bottomed at $1239.0 in Q4 2024.
  • The 3-year median for Gains from Sales and Divestitures is $78378.0 (2025), against an average of $82008.0.
  • The widest annual swing landed in 2025, when Gains from Sales and Divestitures soared 16040.03%; it then jumped 670.56% in 2026.
  • A 3-year view of Gains from Sales and Divestitures shows it stood at $1239.0 in 2024, then jumped by 16040.03% to $199975.0 in 2025, then slumped by 51.96% to $96073.0 in 2026.
  • The last three Gains from Sales and Divestitures figures came in at $96073.0 (Q1 2026), $199975.0 (Q4 2025), and $121610.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Ceribell 666.26 Mn 525.07 Mn 23.12 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 96,073.00
Mar 31, 2026 96,073.00
Dec 31, 2025 199,975.00
Dec 31, 2025 199,975.00
Sep 30, 2025 121,610.00
Sep 30, 2025 121,610.00
Jun 30, 2025 60,683.00
Jun 30, 2025 60,683.00
Mar 31, 2025 12,468.00
Mar 31, 2025 12,468.00
Dec 31, 2024 1,239.00
Dec 31, 2024 1,239.00